Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome02:18

The Proteasome

10.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.2K
The Proteasome01:13

The Proteasome

1.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
The Proteasome02:18

The Proteasome

4.6K
4.6K
The Proteasome Structure01:17

The Proteasome Structure

1.7K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
tRNA Activation02:26

tRNA Activation

23.0K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

QC friendly polysorbate quantification in high concentration protein samples.

Journal of pharmaceutical and biomedical analysis·2026
Same author

Locating Polyubiquitin Receptors on the 19S Regulatory Proteasome of <i>S. cerevisiae</i> by Cross-Linking Mass Spectrometry.

Journal of the American Society for Mass Spectrometry·2025
Same author

Structural Analysis of the 20S Proteasome Using Native Mass Spectrometry and Ultraviolet Photodissociation.

Journal of proteome research·2024
Same author

Bortezomib Inhibits Open Configurations of the 20S Proteasome.

Journal of the American Society for Mass Spectrometry·2024
Same author

Senataxin deficiency disrupts proteostasis through nucleolar ncRNA-driven protein aggregation.

The Journal of cell biology·2024
Same author

Correction to "CDMS Analysis of Intact 19S, 20S, 26S, and 30S Proteasomes: Evidence for Higher-Order 20S Assemblies at a Low pH".

Analytical chemistry·2024

Related Experiment Video

Updated: Feb 5, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K

Scalable In Vitro Proteasome Activity Assay.

Amit Kumar Singh Gautam1, Kirby Martinez-Fonts1, Andreas Matouschek2

  • 1Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.

Methods in Molecular Biology (Clifton, N.J.)
|September 23, 2018
PubMed
Summary

We created a new assay to measure proteasome function using fluorescent protein substrates. This tool helps researchers screen for drugs that modify proteasome activity.

Keywords:
High-throughput degradation assayProteasomeUbiquitin-proteasome system

More Related Videos

Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.1K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K

Related Experiment Videos

Last Updated: Feb 5, 2026

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
09:25

Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain

Published on: May 21, 2019

7.2K
Assaying Proteasomal Degradation in a Cell-free System in Plants
07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.1K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.0K

Area of Science:

  • Biochemistry and Molecular Biology
  • Drug Discovery

Background:

  • The proteasome is a crucial cellular machine responsible for protein degradation.
  • Understanding proteasome function is vital for developing treatments for diseases involving protein homeostasis.
  • Existing assays for proteasome activity can be limited in scope and throughput.

Purpose of the Study:

  • To develop a versatile and high-throughput degradation assay for studying proteasome function.
  • To create a modular fluorescent protein substrate for adaptable proteasome activity measurements.
  • To enable efficient screening of potential proteasome modulators.

Main Methods:

  • Development of a novel fluorescent protein-based substrate for proteasome degradation.
  • The substrate comprises a proteasome-binding tag, a folded domain, and an initiation region.
  • Assay designed for parallel processing in 384-well plates for high-throughput screening.

Main Results:

  • The assay effectively measures the recognition, unfolding, translocation, and hydrolysis of substrates by the proteasome.
  • The modular nature of the substrate allows for customization to modulate degradation rates.
  • The assay demonstrated suitability for exploring diverse experimental conditions and screening proteasome modulators.

Conclusions:

  • A robust and adaptable fluorescent protein-based assay for proteasome degradation has been established.
  • This assay facilitates the investigation of proteasome mechanisms and the discovery of novel therapeutic agents.
  • The high-throughput capability enables efficient screening for compounds that modulate proteasome activity.